Baxter announces increased allocations for certain IV products
Baxter Nov. 26 announced new allocation levels for multiple IV product groups and advised customers of a one- to two-week lead time for products to flow through its supply and distribution network. Allocation and fulfillment levels may vary based on product availability at the time of the order. In a letter shared with customers, Baxter highlighted increased allocations for 0.9% sodium chloride product groups. Its 1000 ml group will increase from 60% to 80%, its 500 ml group from 60% to 90% and its 250 ml group from 60% to 90%. The company said it expects to share details later this month on the next phase of increased allocations and expects to reach 100% allocation across several IV product codes by the end of the month.
Related News Articles
Headline
After incurring damage from Hurricane Helene on Sept. 27, Baxter reports that as of Dec. 19, nearly all of its manufacturing lines in its North Cove, N.C…
Headline
Baxter has resumed production on all of its 3-liter irrigation and peritoneal dialysis solutions manufacturing lines, the company announced Dec. 5. The company…
Headline
The Food and Drug Administration Dec. 4 announced empty IV bags have been added to its Medical Device Shortages List, and that the shortage is estimated to…
Headline
Supplies of Mo-99/Tc-99M, which are medical radioisotopes used in procedures to diagnose and detect diseases including heart disease and cancer, are…
Headline
Baxter announced Oct. 31 that it has restarted its North Cove, N.C. facility's highest-throughput IV solutions manufacturing line, which normally accounts for…
Headline
The AHA Oct. 28 issued a Special Bulletin to members informing them of the Food and Drug Administration's authorization extending the use date for certain…